Skip Nav Destination
1-8 of 8
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Reduced Intensity (RI) Allogeneic Cord Blood Hematopoietic Cell Transplantation (Allo CBHCT) in Pediatric Patients with Malignant and Non-Malignant Diseases.
Gustavo Del Toro, M. B. Bradley, P. Satwani, E. Morris, C. van de Ven, Y.-K. Cheung, D. Yamashiro, J. Garvin, M. Bhatia, E. Roman, J. Schwartz, O. Militano, E. Cooney, K. Wolownik, R. Hawks, S. Foley, M. S. Cairo
Blood (2005) 106 (11): 5463.
Differential mechanisms in the regulation of endogenous levels of thrombopoietin and interleukin-11 during thrombocytopenia: insight into the regulation of platelet production
Blood (1996) 88 (9): 3354–3362.
Decreased interleukin-12 (IL-12) from activated cord versus adult peripheral blood mononuclear cells and upregulation of interferon- gamma, natural killer, and lymphokine-activated killer activity by IL- 12 in cord blood mononuclear cells
Blood (1996) 88 (3): 945–954.
Results of a phase I/II trial of recombinant human granulocyte- macrophage colony-stimulating factor in very low birthweight neonates: significant induction of circulatory neutrophils, monocytes, platelets, and bone marrow neutrophils
Blood (1995) 86 (7): 2509–2515.
A randomized, placebo-controlled trial of recombinant human granulocyte colony-stimulating factor administration in newborn infants with presumed sepsis: significant induction of peripheral and bone marrow neutrophilia
Blood (1994) 84 (5): 1427–1433.
Effect of stem cell factor with and without granulocyte colony- stimulating factor on neonatal hematopoiesis: in vivo induction of newborn myelopoiesis and reduction of mortality during experimental group B streptococcal sepsis
Blood (1992) 80 (1): 96–101.
Circulating granulocyte colony-stimulating factor (G-CSF) levels after allogeneic and autologous bone marrow transplantation: endogenous G-CSF production correlates with myeloid engraftment [see comments]
Blood (1992) 79 (7): 1869–1873.
Seven-day administration of recombinant human granulocyte colony- stimulating factor to newborn rats: modulation of neonatal neutrophilia, myelopoiesis, and group B Streptococcus sepsis
Blood (1990) 76 (9): 1788–1794.